Satovsky Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Satovsky Asset Management's PFE Position: Q1 2026 in Review
Satovsky Asset Management increased its Pfizer (PFE) stake by 1.2% in Q1 2026, buying an estimated $3.94K and bringing the position to 12,856 shares worth $361K. The position accounts for 0.06% of the portfolio, ranked #44.
Satovsky Asset Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $615K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Satovsky Asset Management held 12,856 shares of Pfizer worth $361K as of Q1 2026.
- Satovsky Asset Management bought 148 Pfizer shares in Q1 2026, an estimated $3.94K.
- Pfizer made up 0.06% of Satovsky Asset Management's portfolio in Q1 2026, its #44 holding.
- Satovsky Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Satovsky Asset Management's Pfizer position peaked at $615K in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Satovsky Asset Management's 13F filing for Q1 2026, filed 14 May 2026.